GENOMEPRECISION
Genomeprecision is a molecular diagnostic enterprise integrating R&D, production and sales. It has established “real-time fluorescent quantitative PCR”, “first-generation Sanger sequencing”, “second-generation high-throughput NGS sequencing” and “capillary electrophoresis”. "Fragment Analysis" and "Chemiluminescence CLIA" five molecular diagnostic technology platforms, we will be based on clinical diagnosis and treatment needs to develop molecular diagnostic products based on the above technology platform.
GENOMEPRECISION
Industry:
Biotechnology Health Diagnostics
Founded:
2015-01-01
Status:
Active
Contact:
010-56380026
Total Funding:
14.78 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Apple Mobile Web Clips Icon WordPress Wordpress Plugins Nginx Euro PHP
Similar Organizations
Wayra
Wayra is a globally connected and technologically open innovation hub.
Current Employees Featured
Ye Feng President @ GenomePrecision
President
Founder
Investors List
Juren Capital
Juren Capital investment in Series B - GenomePrecision
Dynamic Balance Capital
Dynamic Balance Capital investment in Series B - GenomePrecision
Yizhuang Biomedical Mergers and Acquisition Funds
Yizhuang Biomedical Mergers and Acquisition Funds investment in Series B - GenomePrecision
China Growth Capital | CGC
China Growth Capital | CGC investment in Series B - GenomePrecision
Sigma Square Capital
Sigma Square Capital investment in Series B - GenomePrecision
Yueyin Venture Capital
Yueyin Venture Capital investment in Series A - GenomePrecision
Sigma Square Capital
Sigma Square Capital investment in Series A - GenomePrecision
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2016-12-14 | GMINIX | GenomePrecision investment in Series A - GMINIX | 10 M CNY |
More informations about "GenomePrecision"
GENOMEPRECISION – Focus on molecular diagnosis , …
Strategic restructuring of GenomePrecision and Search Biotech On May 3, 2016, a grand ceremony was held in the conference hall of Jinghai Industrial […] July 14, 2016See details»
GENOMEPRECISION
旌准医疗高新技术企业证书,思尔成高新技术企业证书,企业科技研究开发机构,北京知识产权试点单位,中关村金种子企业 ...See details»
GenomePrecision - Crunchbase Investor Profile
Genomeprecision is a molecular diagnostic enterprise integrating R&D, production and sales. It has established “real-time fluorescent quantitative …See details»
GenomePrecision - Funding, Financials, Valuation & Investors
GenomePrecision is a national economic and technological development zone. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. …See details»
GenomePrecision Company Profile - Office Locations, Competitors …
GenomePrecision (旌准医疗) is a company that specializes in molecular diagnostics. It focuses on the fluorescent quantitative PCR technology, next-generation sequencing (NGS), visualized …See details»
GenomePrecision - Products, Competitors, Financials, Employees ...
GenomePrecision is a molecular diagnostics enterprise integrating R&D, manufacture, distribution, registration and services. Use the CB Insights Platform to explore …See details»
GenomePrecision - Updates, News, Events, Signals & Triggers
Apr 19, 2021 EqualOcean — GenomePrecision Technology Receives CNY 200 Mn in Series C Funding Round • Feb 18, 2019 GenomePrecision raised CN¥100,000,000 / Series B from …See details»
Next-generation high-throughput …
Skip to content . Home; About Us. Company overview; Corporate culture; Licensure & Certificates; ProductsSee details»
GenomePrecision Secures ¥200 Million in Series C Funding
(VCBeat) Apr. 19, 2021 -- Beijing GenomePrecision Technology Co., Ltd. ("GenomePrecision"), an overall solution provider for molecular diagnostics of hematologic diseases in China, today …See details»
Microfluidics – GENOMEPRECISION
Microfluidics. Microfluidics is a technology that involves the precise manipulation of fluid flow on the microscale. It emerged in the 1980s and since then has seen a fast development and wide …See details»
Beijing GenomePrecision Raises $15 Million for Molecular …
Feb 19, 2019 GenomePrecision Technology of Beijing completed a $15 million B round, led by Yizhuang Biomedical M&A Fund. A six-year-old company, GenomePrecision develops …See details»
GenomePrecision Technology Receives CNY 200 Mn in Series C
Apr 19, 2021 GenomePrecision has announced that it has completed a Series C round financing of CNY 35 million, which is led by Sunland Fund and ZGC Co-Innovation Fund, and followed …See details»
Genome Precision - PitchBook
Www.genomeprecision.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. 5th floor, A3-2, Jinghai Industrial Park; Number …See details»
GenomePrecision - Contacts, Employees, Board Members, …
GenomePrecision is a national economic and technological development zone.See details»
Building the foundation for genomics in precision medicine
Importantly, an organization can both participate in a knowledge-sharing network and contribute their data to ClinVar. By adopting a standardized infrastructure that helps to structure data for …See details»
旌准动态 – 北京旌准医疗科技有限公司 - genomeprecision.com
近日,北京市经济和信息化局网站公布了2021年度第二批北京市专精特新“小巨人”企业名单,北京旌准医疗科技有限 […]See details»
GenomePrecision - Investments, Portfolio & Company Exits
GenomePrecision has invested in GMINIX on Dec 14, 2016. This investment - Series A - GMINIX - was valued at . obfuscated. obfuscated. How many investments has this organization made …See details»
Chemoradiotherapy drugs testing – GENOMEPRECISION
Skip to content . Home; About Us. Company overview; Corporate culture; Licensure & Certificates; ProductsSee details»
Canine genome-wide association study identifies ... - Science | AAAS
Mar 6, 2025 Only one small genome wide association study (GWAS) for obesity has been performed in dogs and it found no significant associations ().However, a few causative …See details»
Self-organization of mouse embryonic stem cells into reproducible …
4 days ago For example, preimplantation blastocyst-like structures are formed by assembling mouse trophoblast stem cells (TSCs) with mESCs, recapitulating the organization and …See details»